Monsha’at: Biban 2024 accelerates transformation of Saudi entrepreneurship with over SAR 10.6 billion worth of agreements

Teva to Present at the Jefferies London Healthcare Conference

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition

Notified -

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition

Bitget Protection Fund Hits $424 Million Average, a 40% Increase from its Initial Commitment

Bright Peak Therapeutics Presents New Data at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

Monsha’at: 23 agreements worth over SAR 580 million signed on Day 3 of Biban 2024

Duck Creek Technologies to Host Third-Annual “One Duck Creek-India Inclusion Summit” in Mumbai 

CNH Industrial N.V. Reports Third Quarter 2024 Results

Fortinet Reports Third Quarter 2024 Financial Results

Lantronix Accelerates IoT Leadership With Strategic Acquisition of DZS’s NetComm Enterprise IoT Portfolio

Algorized Raises $4.3 Million in Seed Funding to Drive Innovation in People-Sensing Technology for Safe Human-Machine Interaction